Trial Profile
Phase I COVID-19 vaccine study for treatment of corona virus infection
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 May 2020
Price :
$35
*
At a glance
- Drugs MT 2766 (Primary)
- Indications Coronavirus infections; COVID 2019 infections
- Focus Adverse reactions
- Sponsors Medicago
- 14 May 2020 According to a Medicago media release, the company will submit an investigational new drug submission with the FDA in the United States to allow for the initiation of human clinical trials this summer.
- 18 Mar 2020 New trial record
- 12 Mar 2020 According to a Medicago media release, the company expects to discuss with the appropriate Health Agencies to initiate human trials of the vaccine by summer (July/August) 2020.